Cover Image
市場調查報告書

前庭病變:全球臨床實驗檢討

Vestibular Diseases Global Clinical Trials Review, H2, 2015

出版商 GlobalData 商品編碼 196192
出版日期 內容資訊 英文 68 Pages
訂單完成後即時交付
價格
Back to Top
前庭病變:全球臨床實驗檢討 Vestibular Diseases Global Clinical Trials Review, H2, 2015
出版日期: 2015年08月07日 內容資訊: 英文 68 Pages
簡介

本報告提供前庭病變治療藥相關臨床研究最新趨勢相關分析、疾病與治療方法概要,及G7及E7各國的臨床實驗狀況、各地區、各階段的進行狀況、有潛力的贊助商、各企業及研究機關的研究進行狀況、有潛力的藥劑比較等資訊彙整,為您概述為以下內容。

目錄

簡介

各地區的臨床實驗趨勢

  • 各國臨床實驗趨勢
    • 歐洲的主要國家
    • 北美的主要國家
    • 中東、非洲的主要國家
    • 中南美的主要國家

G7各國的臨床實驗數量:前庭病變臨床實驗數量的耳鼻咽喉系疾病臨床實驗數量比率

各階段臨床實驗數量: G7各國

G7各國的臨床實驗數量:各階段

E7各國的臨床實驗數量:前庭病變臨床實驗數量的耳鼻咽喉系疾病臨床實驗數量比率

E7各國的臨床實驗數量:各階段

各階段臨床實驗數量

  • 各階段的進展中臨床實驗數量

各進展狀況臨床實驗數量

各評估項目臨床實驗數量

未完成的臨床實驗

一定期間所採用的被實驗人數

贊助商的各種類的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - 前庭病變治療藥

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Sensorion S.A.
    • SK Chemicals Co., Ltd.
    • Neocutis, Inc.
    • Laboratoires Pierre Fabre SA
    • Fuerza Aerea de Chile
    • Apsen Farmaceutica SA
  • 主要大學/實驗室/醫院臨床實驗概要
    • Asan Medical Center
    • Centre Hospitalier Universitaire de Caen
    • Federal University of Sao Paulo
    • Hospital do Servidor Publico Estadual
    • Ludwig Maximilians Universitat Munich
    • McGill University Health Center
    • Norwegian University of Science and Technology
    • Schepens Eye Research Institute
    • Universite de Montreal
    • University Health Network

5大臨床實驗簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2809CTIDB

GlobalData's clinical trial report, "Vestibular Diseases Global Clinical Trials Review, H2, 2015" provides an overview of Vestibular Diseases clinical trials scenario. This report provides top line data relating to the clinical trials on Vestibular Diseases. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Vestibular Diseases
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Vestibular Diseases to Ear Nose Throat Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Vestibular Diseases to Ear Nose Throat Disorders Clinical Trials
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Vestibular Diseases
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Vestibular Diseases Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Sensorion S.A.
      • Clinical Trial Overview of Sensorion S.A.
      • SK Chemicals Co., Ltd.
      • Clinical Trial Overview of SK Chemicals Co., Ltd.
      • Neocutis, Inc.
      • Clinical Trial Overview of Neocutis, Inc.
      • Laboratoires Pierre Fabre SA
      • Clinical Trial Overview of Laboratoires Pierre Fabre SA
      • Fuerza Aerea de Chile
      • Clinical Trial Overview of Fuerza Aerea de Chile
      • Apsen Farmaceutica SA
      • Clinical Trial Overview of Apsen Farmaceutica SA
    • Clinical Trial Overview of Top Institutes / Government
      • Asan Medical Center
      • Clinical Trial Overview of Asan Medical Center
      • Centre Hospitalier Universitaire de Caen
      • Clinical Trial Overview of Centre Hospitalier Universitaire de Caen
      • Federal University of Sao Paulo
      • Clinical Trial Overview of Federal University of Sao Paulo
      • Hospital do Servidor Publico Estadual
      • Clinical Trial Overview of Hospital do Servidor Publico Estadual
      • Ludwig Maximilians Universitat Munich
      • Clinical Trial Overview of Ludwig Maximilians Universitat Munich
      • McGill University Health Center
      • Clinical Trial Overview of McGill University Health Center
      • Norwegian University of Science and Technology
      • Clinical Trial Overview of Norwegian University of Science and Technology
      • Schepens Eye Research Institute
      • Clinical Trial Overview of Schepens Eye Research Institute
      • Universite de Montreal
      • Clinical Trial Overview of Universite de Montreal
      • University Health Network
      • Clinical Trial Overview of University Health Network
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Vestibular Diseases Therapeutics, Global, Clinical Trials by Region, 2015*
  • Vestibular Diseases Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Vestibular Diseases Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Vestibular Diseases Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Vestibular Diseases Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Vestibular Diseases Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Vestibular Diseases Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Vestibular Diseases Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Vestibular Diseases to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2015*
  • Vestibular Diseases Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Vestibular Diseases Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Vestibular Diseases to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2015*
  • Vestibular Diseases Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Vestibular Diseases Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Vestibular Diseases Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Vestibular Diseases Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Vestibular Diseases Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Vestibular Diseases Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Vestibular Diseases Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Vestibular Diseases Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Vestibular Diseases Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Vestibular Diseases Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Vestibular Diseases Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Vestibular Diseases Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Sensorion S.A., 2015*
  • Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by SK Chemicals Co., Ltd., 2015*
  • Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Neocutis, Inc., 2015*
  • Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Pierre Fabre SA, 2015*
  • Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Fuerza Aerea de Chile, 2015*
  • Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Apsen Farmaceutica SA, 2015*
  • Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2015*
  • Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Caen, 2015*
  • Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2015*
  • Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital do Servidor Publico Estadual, 2015*
  • Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Ludwig Maximilians Universitat Munich, 2015*
  • Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by McGill University Health Center, 2015*
  • Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Norwegian University of Science and Technology, 2015*
  • Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Schepens Eye Research Institute, 2015*
  • Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Universite de Montreal, 2015*
  • Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2015*

List of Figures

  • Vestibular Diseases Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Vestibular Diseases Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Vestibular Diseases Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Vestibular Diseases Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Vestibular Diseases Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Vestibular Diseases Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Vestibular Diseases to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2015*
  • Vestibular Diseases Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Vestibular Diseases Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Vestibular Diseases to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2015*
  • Vestibular Diseases Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Vestibular Diseases Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Vestibular Diseases Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Vestibular Diseases Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Vestibular Diseases Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Vestibular Diseases Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Vestibular Diseases Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Vestibular Diseases Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Vestibular Diseases Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Vestibular Diseases Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top